Bank of America disclosed a 2.1% stake in the Irish drugmaker Avadel Pharmaceuticals plc, according to a regulatory filing submitted on December 24, 2025.
The total holding amounts to 2,059,719 ordinary shares. This figure includes 1,557,556 owned or controlled shares and 502,163 cash-settled derivatives.
Filed under the rules of the Irish Takeover Panel, the disclosure also detailed BofA's short positions. The bank holds 1,034,588 short shares, representing approximately 1.062% of Avadel.
The filing specified multiple purchases and sales executed on December 23. These transactions occurred at prices ranging from $21.47 to $21.65.